408 related articles for article (PubMed ID: 29040533)
1. Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease.
Kandimalla R; Manczak M; Yin X; Wang R; Reddy PH
Hum Mol Genet; 2018 Jan; 27(1):30-40. PubMed ID: 29040533
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer's disease.
Manczak M; Kandimalla R; Yin X; Reddy PH
Hum Mol Genet; 2018 Apr; 27(8):1332-1342. PubMed ID: 29408999
[TBL] [Abstract][Full Text] [Related]
3. Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
Kandimalla R; Manczak M; Fry D; Suneetha Y; Sesaki H; Reddy PH
Hum Mol Genet; 2016 Nov; 25(22):4881-4897. PubMed ID: 28173111
[TBL] [Abstract][Full Text] [Related]
4. Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer's disease.
Reddy PH; Yin X; Manczak M; Kumar S; Pradeepkiran JA; Vijayan M; Reddy AP
Hum Mol Genet; 2018 Jul; 27(14):2502-2516. PubMed ID: 29701781
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer's disease.
Reddy AP; Sawant N; Morton H; Kshirsagar S; Bunquin LE; Yin X; Reddy PH
Hum Mol Genet; 2021 May; 30(9):789-810. PubMed ID: 33791799
[TBL] [Abstract][Full Text] [Related]
6. A partial reduction of Drp1 improves cognitive behavior and enhances mitophagy, autophagy and dendritic spines in a transgenic Tau mouse model of Alzheimer disease.
Kandimalla R; Manczak M; Pradeepkiran JA; Morton H; Reddy PH
Hum Mol Genet; 2022 Jun; 31(11):1788-1805. PubMed ID: 34919689
[TBL] [Abstract][Full Text] [Related]
7. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
8. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
[TBL] [Abstract][Full Text] [Related]
9. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.
Manczak M; Calkins MJ; Reddy PH
Hum Mol Genet; 2011 Jul; 20(13):2495-509. PubMed ID: 21459773
[TBL] [Abstract][Full Text] [Related]
10. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Jun; 21(11):2538-47. PubMed ID: 22367970
[TBL] [Abstract][Full Text] [Related]
11. Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer's Disease.
Kshirsagar S; Alvir RV; Hindle A; Kumar S; Vijayan M; Pradeepkiran JA; Reddy AP; Ramasubramanian B; Reddy PH
Cells; 2022 Feb; 11(4):. PubMed ID: 35203382
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.
Chabrier MA; Cheng D; Castello NA; Green KN; LaFerla FM
Neurobiol Dis; 2014 Apr; 64():107-17. PubMed ID: 24440055
[TBL] [Abstract][Full Text] [Related]
13. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
14. Chronic cerebral hypoperfusion accelerates Alzheimer's disease pathology with the change of mitochondrial fission and fusion proteins expression in a novel mouse model.
Feng T; Yamashita T; Zhai Y; Shang J; Nakano Y; Morihara R; Fukui Y; Hishikawa N; Ohta Y; Abe K
Brain Res; 2018 Oct; 1696():63-70. PubMed ID: 29879414
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of a small molecule inhibitor, DDQ against amyloid beta in Alzheimer's disease.
Vijayan M; Bose C; Reddy PH
Mitochondrion; 2021 Jul; 59():17-29. PubMed ID: 33839321
[TBL] [Abstract][Full Text] [Related]
16. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
[TBL] [Abstract][Full Text] [Related]
18. The role of hippocampal tau protein phosphorylation in isoflurane-induced cognitive dysfunction in transgenic APP695 mice.
Li C; Liu S; Xing Y; Tao F
Anesth Analg; 2014 Aug; 119(2):413-419. PubMed ID: 24977637
[TBL] [Abstract][Full Text] [Related]
19. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
[TBL] [Abstract][Full Text] [Related]
20. Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice.
Xu H; Rösler TW; Carlsson T; de Andrade A; Bruch J; Höllerhage M; Oertel WH; Höglinger GU
Neuropathol Appl Neurobiol; 2014 Dec; 40(7):833-43. PubMed ID: 24865638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
